Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00408707
Status:
COMPLETED
Last Update Posted:
2008-02-29
First Post:
2006-12-06
Brief Title:
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Knee Arthroplasty
Sponsor:
Hvidovre University Hospital
Organization:
Hvidovre University Hospital
Study Overview
Official Title:
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Knee Arthroplasty a Placebo Controlled Randomized Double-Blinded Study
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine whether local infiltration analgesia LIA with Ropivacaine and adrenaline is effective in the treatment of postoperative pain after total knee arthroplasty
Detailed Description:
Total knee arthroplasty TKA is increasingly common in the treatment of osteoarthrosis Despite aggressive analgesic regimes TKA is associated with moderate to severe postoperative pain delaying mobilization and hospital discharge A relatively new method for controlling postoperative pain after TKA is local infiltration analgesia LIA which consists of local infiltration with Ropivacaine and adrenaline3 studies haved showed promising results of LIA but none have documented a superior analgesic effect versus placeboPatients receiving bilateral knee arthroplasty are recruited to receive LIA and placebo infiltrationThe aim of the study is to demonstrate an analgesic effect of LIA versus placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None